▟ Vinebot intrinsic value, daily

← back

UNH UnitedHealth Group

healthcare · valued with opus medium conviction · deep-dived 2026-11-18

BUY
Intrinsic value$285.58
Price (at call)$389.68
Margin of safety -26.7%
vs market (rating basis) +27.2%

Margin repair is ahead of schedule, but a regulated 6% ceiling still leaves price above value.

The story

UnitedHealth is the largest US managed-care and health-services platform, pairing UnitedHealthcare's insurance scale with Optum's care-delivery, PBM and data businesses in a vertically integrated loop that peers cannot easily copy. It is a mature franchise growing with healthcare spending. The 2024-2025 margin collapse came from elevated medical cost trend, Medicare Advantage rate pressure, and regulatory and DOJ scrutiny of the Optum integration. TTM operating margin has recovered to 5.2% from 4.2%, so the repair is real, but rate regulation and political risk cap how far it can go.

TTM operating margin has already reached 5.2%, close to my prior 5.5% target. So I am raising the target modestly to 6.0% (a 9% relative move, not material) and shortening margin_years from 6 to 5 because the repair is arriving faster than I expected. That 6.0% is still well below the 8.7% peak, because MA rate pressure, PBM reform and Optum vertical-integration scrutiny make the old margins unlikely to come back. All other drivers stay the same: growth tracks healthcare spending, reinvestment efficiency matches the observed 2.61, and the 8-year horizon fits a scaled but regulated franchise.

Value drivers

Revenue growth (Y1)5.5%
Terminal growth3.5%
Forecast horizon8y
Target operating margin6.0%
Years to target margin5
Sales-to-capital2.60
Beta1.05
Failure probability3.0%
Cost of capital (WACC)9.1%
Terminal WACC8.9%

Valuation bridge

PV of explicit FCFF101.69B
PV of terminal value223.72B
Equity value255.89B
÷ shares → per share$285.58

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 474.39B 5.5% 5.4% 22.31B 9.51B 12.80B 11.73B
2 499.13B 5.2% 5.5% 24.13B 9.51B 14.61B 12.27B
3 523.73B 4.9% 5.7% 26.01B 9.46B 16.54B 12.73B
4 548.05B 4.6% 5.8% 27.93B 9.35B 18.58B 13.11B
5 571.92B 4.4% 6.0% 29.90B 9.18B 20.72B 13.39B
6 595.21B 4.1% 6.0% 31.12B 8.96B 22.16B 13.13B
7 617.74B 3.8% 6.0% 32.30B 8.67B 23.63B 12.83B
8 639.36B 3.5% 6.0% 33.43B 8.32B 25.11B 12.49B

Key risks

  • Medicare Advantage rate notices and risk-adjustment (V28) changes compress UnitedHealthcare margins further
  • DOJ or legislative action forcing structural separation of Optum or PBM reform hitting OptumRx economics
  • Medical cost trend staying elevated, so pricing lags utilization for another cycle

Catalysts

  • Medical care ratio normalization showing up in 2027 guidance and repricing of MA bids
  • Favorable 2027-2028 CMS final rate notices or resolution of DOJ investigations

History

DatePriceIntrinsicMoSRating
2026-11-18$389.68 $285.58 -26.7% BUY
2026-09-29$377.83 $231.35 -38.8% BUY
2026-08-10$407.08 $203.83 -49.9% HOLD
2026-06-23$409.25 $250.35 -38.8% BUY